SK143697A3 - A process for preparing form 1 ranitidine hydrochloride - Google Patents

A process for preparing form 1 ranitidine hydrochloride Download PDF

Info

Publication number
SK143697A3
SK143697A3 SK1436-97A SK143697A SK143697A3 SK 143697 A3 SK143697 A3 SK 143697A3 SK 143697 A SK143697 A SK 143697A SK 143697 A3 SK143697 A3 SK 143697A3
Authority
SK
Slovakia
Prior art keywords
ranitidine
reaction mixture
hydrochloride
methylene chloride
ratio
Prior art date
Application number
SK1436-97A
Other languages
English (en)
Slovak (sk)
Inventor
Helmut Schickaneder
Aggelos Nikolopoulos
Original Assignee
Hexal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Pharmaceuticals Inc filed Critical Hexal Pharmaceuticals Inc
Publication of SK143697A3 publication Critical patent/SK143697A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1436-97A 1995-04-21 1996-01-26 A process for preparing form 1 ranitidine hydrochloride SK143697A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/426,930 US5663381A (en) 1995-04-21 1995-04-21 Process for preparing form 1 ranitidine hydrochloride
PCT/US1996/000992 WO1996033185A1 (en) 1995-04-21 1996-01-26 A process for preparing form 1 ranitidine hydrochloride

Publications (1)

Publication Number Publication Date
SK143697A3 true SK143697A3 (en) 1998-05-06

Family

ID=23692783

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1436-97A SK143697A3 (en) 1995-04-21 1996-01-26 A process for preparing form 1 ranitidine hydrochloride

Country Status (17)

Country Link
US (1) US5663381A (cs)
JP (1) JPH11503755A (cs)
KR (1) KR19990007912A (cs)
AU (1) AU691736B2 (cs)
BG (1) BG101982A (cs)
BR (1) BR9608177A (cs)
CA (1) CA2218562A1 (cs)
CZ (1) CZ332097A3 (cs)
EE (1) EE9700291A (cs)
FI (1) FI974002L (cs)
HU (1) HUP9801658A2 (cs)
NO (1) NO974846L (cs)
NZ (1) NZ302872A (cs)
PL (1) PL322979A1 (cs)
SI (1) SI9620056A (cs)
SK (1) SK143697A3 (cs)
WO (1) WO1996033185A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004985A (en) * 1996-10-09 1999-12-21 Berlex Laboratories, Inc. Thio acid derived monocylic N-heterocyclics as anticoagulants
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
IT1317858B1 (it) 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
KR101085806B1 (ko) * 2003-07-29 2011-11-22 다이닛본 스미토모 세이야꾸 가부시끼가이샤 이미드 화합물의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
WO1996033185A1 (en) 1996-10-24
NZ302872A (en) 1998-04-27
FI974002A0 (fi) 1997-10-20
NO974846L (no) 1997-12-19
CZ332097A3 (cs) 1998-03-18
FI974002A7 (fi) 1997-12-03
MX9708122A (es) 1998-06-28
US5663381A (en) 1997-09-02
AU4903296A (en) 1996-11-07
FI974002L (fi) 1997-12-03
AU691736B2 (en) 1998-05-21
HUP9801658A2 (hu) 1999-09-28
BR9608177A (pt) 2000-10-31
PL322979A1 (en) 1998-03-02
CA2218562A1 (en) 1996-10-24
BG101982A (bg) 1998-04-30
NO974846D0 (no) 1997-10-20
KR19990007912A (ko) 1999-01-25
SI9620056A (sl) 1998-04-30
EE9700291A (et) 1998-06-15
JPH11503755A (ja) 1999-03-30

Similar Documents

Publication Publication Date Title
SK403591A3 (en) 2-ranitidine hydrochloride form, method of its preparation and pharmaceutical product with its contents
EP2311821A1 (en) Polymorphic form of Imatinib mesylate and processes for its preparation
CZ301778B6 (cs) Modifikace 2-amino-4-(4-fluorbenzylamino)-1-ethoxykarbonylaminobenzenu, zpusoby jejich prípravy, jejich použití a lécivo, které je obsahuje
EP0066459B1 (en) Crystalline benzothiazine dioxide salts
KR100588254B1 (ko) 결정 형태의ｎ-(4-트리플루오로메틸페닐)-5-메틸이속사졸-4-카복스아미드
CN102321019B (zh) 喹啉化合物的晶形及其生产方法
SK286422B6 (sk) Hydrát 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jehovýroby, farmaceutický prípravok s jeho obsahom a jeho použitie
EP0579681A1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
US11897858B2 (en) Salt and solid state forms of escatalopram
SK286618B6 (sk) Hydrát 5-[4-[2-N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jeho výroby, farmaceutický prípravok s jeho obsahom a jeho použitie
CY1274A (en) 3-indolyl-tertiary butylaminopropanols
SK143697A3 (en) A process for preparing form 1 ranitidine hydrochloride
KR870000291B1 (ko) 결정상 벤조티아진 디옥사이드 염의 제조방법
KR820002280B1 (ko) 벤즈 이미다졸의 제조방법
CN102086212A (zh) 抗真菌剂-2，3，4，5-四氢-4H-苯并[b]噻喃并[4，3-c]吡唑-2-甲酰胺衍生物
BG106139A (bg) Полиморфи на кристален (2-бензхидрил-1-азабицикло/2.2.2/окт-3-ил)-(5-изопропил-2-метоксибензил)-амин цитрат като nk-1-рецепторни антагонисти
JPS6410512B2 (cs)
MXPA97008122A (en) A process for preparing ranitidine hydrochloride form
EP1927591A1 (en) Polymorphic Forms of Deferasirox (ICL670)
JPS63126860A (ja) グアニジノメチル安息香酸誘導体
JPS60188373A (ja) 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
KR790001260B1 (ko) 크산틴 유도체의 제조방법
HK1012629B (en) Terazosin monohydrochloride and processes and intermediate for its production
JPS5857429B2 (ja) グアニジン類の製法
ZA200303000B (en) Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation.